| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT06962800 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… |
Trial sites expanded: 97 -> 100 locations |
| 2026-06-06 | NCT05828953 Anlotinib Capsules in the Treatment for IPF/PF-ILDs |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-06 | NCT05828953 Anlotinib Capsules in the Treatment for IPF/PF-ILDs |
Phase changed: ['PHASE2', 'PHASE3'] -> ['PHASE2'] |
| 2026-06-06 | NCT05828953 Anlotinib Capsules in the Treatment for IPF/PF-ILDs |
Primary endpoint(s) modified |
| 2026-06-06 | NCT05828953 Anlotinib Capsules in the Treatment for IPF/PF-ILDs |
date change Primary completion pushed: 2026-03-04 -> 2026-09-30 |
| 2026-06-06 | NCT07204275 Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With… |
Trial sites expanded: 93 -> 98 locations |
| 2026-06-06 | NCT07412470 A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults… |
Trial sites expanded: 16 -> 23 locations |
| 2026-06-05 | NCT06872333 Allo HSCT for High Risk Hemoglobinopathies |
Trial arms changed: 4 -> 5 |
| 2026-06-02 | NCT06654882 Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis |
date change Primary completion pushed: 2026-06 -> 2026-12 |
| 2026-05-21 | NCT07412470 A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults… |
Trial sites expanded: 10 -> 16 locations |
| 2026-05-15 | NCT07566377 Cord Blood Transplantation in Children and Young Adults With Blood Cancer |
Trial arms changed: 6 -> 2 |
| 2026-05-15 | NCT07566377 Cord Blood Transplantation in Children and Young Adults With Blood Cancer |
Trial sites reduced: 7 -> 1 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07634536 Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell… | Phase 2 | Not Yet Recruiting |
| 2026-06-09 | NCT07636226 QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer | Phase 2/3 | Not Yet Recruiting |
| 2026-06-08 | NCT07632209 Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small… | Phase 2 | Not Yet Recruiting |
| 2026-06-01 | NCT07616154 Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease | Phase 2 | Not Yet Recruiting |
| 2026-05-28 | NCT07612098 Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma | Phase 2 | Not Yet Recruiting |
| 2026-05-20 | NCT07599176 Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors | Phase 1/2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06529536 | Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ… | Solid Organ Transplant | Recruiting |
| NCT02081755 | Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer | Carcinoma, Hepatocellular | Enrolling by Invitation |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT04474847 | Abatacept for the Treatment of Giant Cell Arteritis | Giant Cell Arteritis | Recruiting |
| NCT04877288 | A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney… | Renal Allograft Recipients | Recruiting |
| NCT03016819 | Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma… | Alveolar Soft Part Sarcoma | Recruiting |
| NCT07443397 | Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients. | Whole-Brain Radiotherapy | Recruiting |
| NCT06615050 | A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant… | Graft-versus-host Disease (GVHD) | Recruiting |
| NCT06654882 | Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis | Polyarticular Course Juvenile Idiopathic Arthritis (JIA) | Recruiting |
| NCT06235892 | Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA… | Organ Grafts | Recruiting |
| NCT06962800 | A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… | Primary Membranous Nephropathy | Recruiting |
| NCT03480360 | Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune… | Acute Myeloid Leukemia | Active, Not Recruiting |
| NCT04629248 | A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary… | Primary Membranous Nephropathy | Active, Not Recruiting |
| NCT07540390 | GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC. | Nasopharyngeal Carcinoma | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07366801 | Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell… | Acute Myeloid Leukemia, Relapsed | Recruiting |
| NCT04302870 | Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial | Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Recruiting |
| NCT03321656 | Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic… | End Stage Renal Disease | Recruiting |
| NCT07204275 | Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With… | Primary Membranous Nephropathy | Recruiting |
| NCT07412470 | A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults… | Kidney Transplant Rejection | Recruiting |
| NCT05707377 | A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary… | Primary Membranous Nephropathy | Active, Not Recruiting |
| NCT07636226 | QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer | Small Cell Lung Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT07330544 | A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant… | Breast Cancer | Recruiting |
| NCT04370301 | Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or… | Primary Myelofibrosis | Recruiting |
| NCT07228624 | Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With… | Myelodysplastic/Myeloproliferative Neoplasm | Recruiting |
| NCT06345495 | High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients… | Splenomegaly | Recruiting |